Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Ajanta Pharma Limited ( (IN:AJANTPHARM) ) is now available.
Ajanta Pharma Limited has announced that it will release its audited financial results for the fourth quarter of the fiscal year 2025 on April 30, 2025. The company will host an earnings conference call on the same day, where the leadership team will discuss the financial performance and engage with stakeholders through a Q&A session. This announcement is significant for stakeholders as it provides insights into the company’s financial health and strategic direction.
More about Ajanta Pharma Limited
Ajanta Pharma Limited is a pharmaceutical company based in Mumbai, India. It specializes in the development, manufacturing, and marketing of pharmaceutical products, focusing on branded generics in therapeutic segments such as anti-malarial, cardiology, dermatology, and ophthalmology. The company serves markets across India, Asia, Africa, and the United States.
YTD Price Performance: -10.81%
Average Trading Volume: 4,596
Current Market Cap: 334.5B INR
See more data about AJANTPHARM stock on TipRanks’ Stock Analysis page.